RxDoctor Payments Data

Douglas Mehr, MD

Retina Specialist · West Jordan, UTNPI 1720070899

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $737, 6.0 times the $123 reported in 2019. That places this record below the midpoint for retina specialist clinicians in UT, where the typical reported total is $2,710.

$2,710in general payments, 2019–2025

Across 125 payments — averaging $21.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$633
  • Genentech USA, Inc.$561
  • AbbVie$361
  • Eyepoint US, Inc.$249
  • Astellas Pharma US Inc$216
  • Apellis Pharmaceuticals, Inc.$202
  • plus $488 from 10 others
$30,984in research payments, 2019–2025

Across 2 payments — averaging $15,492 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Roche TCRC, Inc.$31K

What the payments were for

  • Food & beverage$2,710100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,710 in reported general payments places this provider in the 50th percentile of 20 retina specialist providers in Utah.

See all retina specialist providers in Utah

Medicare billing

Part B allowed, 2024
$4,292,319
Medicare patients
588
Services billed
55,751

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate120$4,702
Diclofenac Sodium341$3,911
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat236$3,066
Latanoprost119$1,278
MoxifloxacinMoxifloxacin Hcl54$1,202
Ketorolac Tromethamine24$677
Brimonidine Tartrate55$456
Ciprofloxacin Hcl34$443
Timolol Maleate15$243
ErythromycinErythromycin Base14$153
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$91

Paid to pharmacies, not to this prescriber.

Other retina specialist in West Jordan

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →